| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |